Thomas Danne

13.5k total citations · 1 hit paper
114 papers, 3.6k citations indexed

About

Thomas Danne is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Thomas Danne has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Endocrinology, Diabetes and Metabolism, 68 papers in Surgery and 60 papers in Genetics. Recurrent topics in Thomas Danne's work include Diabetes Management and Research (97 papers), Pancreatic function and diabetes (61 papers) and Diabetes and associated disorders (58 papers). Thomas Danne is often cited by papers focused on Diabetes Management and Research (97 papers), Pancreatic function and diabetes (61 papers) and Diabetes and associated disorders (58 papers). Thomas Danne collaborates with scholars based in Germany, United States and Sweden. Thomas Danne's co-authors include Olga Kordonouri, Karin Lange, Darren K. McGuire, Anne L. Peters, Phillip Banks, Jake A. Kushner, Paul Strumph, Pablo Lapuerta, Peter Swift and Satish K. Garg and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Diabetes.

In The Last Decade

Thomas Danne

107 papers receiving 3.4k citations

Hit Papers

Effects of Sotagliflozin Added to Insulin in Patients wit... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
    2017 305 citations Satish K. Garg, Phillip Banks et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Danne Germany 34 3.0k 2.1k 1.7k 246 209 114 3.6k
Ralph Ziegler Germany 26 1.3k 0.4× 788 0.4× 856 0.5× 153 0.6× 92 0.4× 130 2.0k
Jeremy Pettus United States 28 2.2k 0.7× 1.5k 0.7× 1.1k 0.7× 385 1.6× 45 0.2× 74 2.9k
Anna Lindholm Olinder Sweden 24 1.3k 0.4× 768 0.4× 464 0.3× 253 1.0× 413 2.0× 72 2.3k
S. P. Laing United Kingdom 12 988 0.3× 427 0.2× 423 0.2× 225 0.9× 93 0.4× 15 1.6k
Sofia Dahlqvist Sweden 16 2.1k 0.7× 1.0k 0.5× 941 0.6× 263 1.1× 30 0.1× 25 2.6k
Luís Eduardo Calliari Brazil 17 729 0.2× 305 0.1× 424 0.2× 152 0.6× 88 0.4× 69 1.1k
S. D. Slater United Kingdom 13 962 0.3× 325 0.2× 400 0.2× 241 1.0× 80 0.4× 31 1.6k
W. Gatling United Kingdom 21 1.2k 0.4× 349 0.2× 281 0.2× 309 1.3× 58 0.3× 38 1.9k
Curt L. Rohlfing United States 22 2.1k 0.7× 364 0.2× 524 0.3× 609 2.5× 76 0.4× 34 2.9k
Alfonso Galderisi Italy 19 770 0.3× 439 0.2× 397 0.2× 186 0.8× 132 0.6× 96 1.3k

Countries citing papers authored by Thomas Danne

Since Specialization
Citations

This map shows the geographic impact of Thomas Danne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Danne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Danne more than expected).

Fields of papers citing papers by Thomas Danne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Danne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Danne. The network helps show where Thomas Danne may publish in the future.

Co-authorship network of co-authors of Thomas Danne

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Danne. A scholar is included among the top collaborators of Thomas Danne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Danne. Thomas Danne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Saboo, Banshi, et al.. (2024). Current and Future Strategies in Insulin Development and Treatment. Hormone Research in Paediatrics. 98(4). 396–404. 2 indexed citations
4.
Kordonouri, Olga, et al.. (2023). Direct LDL-C estimation in preschoolers: Practicable first step for FH screening. Journal of clinical lipidology. 17(2). 255–260. 1 indexed citations
5.
Šuštar, Urša, Olga Kordonouri, Matej Mlinarič, et al.. (2022). Universal screening for familial hypercholesterolemia in 2 populations. Genetics in Medicine. 24(10). 2103–2111. 23 indexed citations
6.
Danne, Thomas, Catarina Limbert, Manel Puig‐Domingo, et al.. (2021). Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future. Diabetes Therapy. 12(9). 2289–2310. 32 indexed citations
7.
Grimsmann, Julia M., Christina Reinauer, Andreas Melmer, et al.. (2020). Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry. Diabetes Technology & Therapeutics. 22(8). 602–612. 33 indexed citations
8.
Danne, Thomas, Vijay N. Joish, Phillip Banks, et al.. (2020). Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone. Diabetes Technology & Therapeutics. 23(1). 70–77. 7 indexed citations
9.
Bode, Bruce W., Violeta Iotova, М. А. Коваренко, et al.. (2019). Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial. Diabetes Care. 42(7). 1255–1262. 46 indexed citations
10.
11.
Ziegler, Anette‐G., Georg F. Hoffmann, Joerg Hasford, et al.. (2019). Screening for asymptomatic β-cell autoimmunity in young children. The Lancet Child & Adolescent Health. 3(5). 288–290. 9 indexed citations
12.
Buse, John B., Satish K. Garg, Julio Rosenstock, et al.. (2018). Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 41(9). 1970–1980. 172 indexed citations
13.
Danne, Thomas, David B. Dunger, Reinhard Berner, et al.. (2016). Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Molecular Metabolism. 5(4). 255–262. 38 indexed citations
14.
15.
Danne, Thomas & Jan Bolinder. (2012). New insulins and insulin therapy. International Journal of Clinical Practice. 66. 30–34.
16.
Cinek, Ondřej, Zdenĕk Šumnı́k, Carine de Beaufort, et al.. (2012). Heterogeneity in the systems of pediatric diabetes care across the European Union. Pediatric Diabetes. 13. 5–14. 16 indexed citations
17.
Danne, Thomas, Olga Kordonouri, Martin Holder, et al.. (2011). Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy. Diabetes Technology & Therapeutics. 13(11). 1129–1134. 108 indexed citations
18.
19.
Lange, Karin, Heike Saßmann, Wolfgang Schütz, Olga Kordonouri, & Thomas Danne. (2007). Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany. Pediatric Diabetes. 8(s6). 63–71. 43 indexed citations
20.
Kordonouri, Olga, et al.. (2002). Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabetic Medicine. 19(6). 518–521. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph Ziegler Breakdown of academic impact, for papers by Jeremy Pettus Breakdown of academic impact, for papers by Anna Lindholm Olinder Breakdown of academic impact, for papers by S. P. Laing Breakdown of academic impact, for papers by Sofia Dahlqvist Breakdown of academic impact, for papers by Luís Eduardo Calliari Breakdown of academic impact, for papers by S. D. Slater Breakdown of academic impact, for papers by W. Gatling Breakdown of academic impact, for papers by Curt L. Rohlfing Breakdown of academic impact, for papers by Alfonso Galderisi
Rankless by CCL
2026